SCHEMBL30402030

SCHEMBL30402030

CN(C)c1ccc(N=C(c2ccccc2)c2ccccc2)cc1C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 6/20 0.40
▸ ESR2 Q92731 6/20 0.40
▸ HTR3E A5X5Y0 1/20 0.37
▸ HTR3B O95264 1/20 0.37
▸ HTR3A P46098 1/20 0.37
▸ HTR3D Q70Z44 1/20 0.37
▸ HTR3C Q8WXA8 1/20 0.37
▸ ACP1 P24666 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ NOTUM Q6P988 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CLK4 Q9HAZ1 1/20 0.32
▸ PDK2 Q15119 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24399684 0.80 CYP3A4 (0.44) ESR1ESR2HTR3EHTR3BHTR3A
SCHEMBL3501395 0.79 TDP1 (0.49) ACP1ALDH1A1NOTUMSMN1; SMN2
SCHEMBL3501392 0.79 TDP1 (0.49) ACP1ALDH1A1NOTUMSMN1; SMN2
SCHEMBL8586278 0.78 MAPT (0.50) ESR1ESR2HTR3EHTR3BHTR3A
SCHEMBL6135928 0.76 ESR1 (0.44) ESR1ESR2HTR3EHTR3BHTR3A
SCHEMBL29220712 0.70 HTR3E (0.55) ESR1ESR2HTR3EHTR3BHTR3A
SCHEMBL6606026 0.68 ALDH1A1 (0.39) ESR1ESR2ACP1ALDH1A1HPGD
SCHEMBL29893557 0.67 AR (0.52) —
SCHEMBL1768874 0.66 ACP1 (0.46) ESR1ACP1ALDH1A1NOTUMSMN1; SMN2
SCHEMBL30454780 0.66 ACP1 (0.46) ESR1ACP1ALDH1A1NOTUMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116096718-A Aryl amide compound, pharmaceutical composition containing same, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2023-05-09 — — CN disclosed
Send feedback